| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Departments of Pathology [M. S., R. H. H., L. H., K. R. C., G. M. N., C. W., G. S. B., S. A. H., S. E. K.], Oncology [R. H. H., G. S. B., W. B. I., D. S. R. A. C., S. E. K.], Urology [G. S. B., W. B. I.], and Otolaryngology [P. C., H. N., D. S.], The Johns Hopkins Medical Institutions, Baltimore, Maryland 21205-2196, and Laboratory of Cancer Genetics, National Center of Human Genome Research, National Institutes of Health, Bethesda, Maryland 20892 [P. S. M.]
We recently identified a novel tumor-suppressor gene, DPC4, at chromosome 18q21.1 and found that both alleles of DPC4 were inactivated in nearly one-half of the pancreatic carcinomas. Here, we analyzed 338 tumors, originating from 12 distinct anatomic sites, for alterations in the DPC4 gene. Sixty-four specimens were selected for the presence of the allelic loss of 18q and were further analyzed for DPC4 sequence alterations. An alteration of the DPC4 gene sequence was identified in one of eight breast carcinomas and one of eight ovarian carcinomas. These results indicate that whereas DPC4 inactivation is prevalent in pancreatic carcinoma (48%), it is distinctly uncommon (<10%) in the other tumor types examined. The tissue restriction of alterations in DPC4, as in many other tumor-suppressor genes, emphasizes the complexity of rate-limiting checkpoints in human tumorigenesis.
1 This work was supported by the SPORE (Specialized Program of Research Excellence) for Gastrointestinal Cancer, NIH Grant CA62924. S. E. K. is a McDonnell Foundation Scholar.
2 To whom requests for reprints should be addressed, at Department of Oncology, The Johns Hopkins Medical Institutions, Baltimore, MD 21205-2196. Phone: (410) 614-3314; Fax: 614-0671.
Received 4/ 5/96. Accepted 4/15/96.
This article has been cited by other articles:
![]() |
V. Dixit and R. L. Juliano Selective Killing of Smad4-Negative Tumor Cells via a Designed Repressor Strategy Mol. Pharmacol., July 1, 2008; 74(1): 289 - 297. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhao, K. Venkatasubbarao, J. W. Lazor, J. Sperry, C. Jin, L. Cao, and J. W. Freeman Inhibition of STAT3Tyr705 Phosphorylation by Smad4 Suppresses Transforming Growth Factor {beta}-Mediated Invasion and Metastasis in Pancreatic Cancer Cells Cancer Res., June 1, 2008; 68(11): 4221 - 4228. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Di Bartolo, M. Cannon, Y.-F. Liu, R. Renne, A. Chadburn, C. Boshoff, and E. Cesarman KSHV LANA inhibits TGF-{beta} signaling through epigenetic silencing of the TGF-{beta} type II receptor Blood, May 1, 2008; 111(9): 4731 - 4740. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhao, S. Ammanamanchi, M. Brattain, L. Cao, A. Thangasamy, J. Wang, and J. W. Freeman Smad4-dependent TGF-{beta} Signaling Suppresses RON Receptor Tyrosine Kinase-dependent Motility and Invasion of Pancreatic Cancer Cells J. Biol. Chem., April 25, 2008; 283(17): 11293 - 11301. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Feldmann and A. Maitra Molecular Genetics of Pancreatic Ductal Adenocarcinomas and Recent Implications for Translational Efforts J. Mol. Diagn., March 1, 2008; 10(2): 111 - 122. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Pan, T. Schomber, C. P. Kalberer, L. M. Terracciano, K. Hafen, W. Krenger, H. Hao-Shen, C. Deng, and R. C. Skoda Normal erythropoiesis but severe polyposis and bleeding anemia in Smad4-deficient mice Blood, October 15, 2007; 110(8): 3049 - 3055. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kojima, S. M. Vickers, N. V. Adsay, N. C. Jhala, H.-G. Kim, T. R. Schoeb, W. E. Grizzle, and C. A. Klug Inactivation of Smad4 Accelerates KrasG12D-Mediated Pancreatic Neoplasia Cancer Res., September 1, 2007; 67(17): 8121 - 8130. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Dennler, J. Andre, I. Alexaki, A. Li, T. Magnaldo, P. ten Dijke, X.-J. Wang, F. Verrecchia, and A. Mauviel Induction of Sonic Hedgehog Mediators by Transforming Growth Factor-{beta}: Smad3-Dependent Activation of Gli2 and Gli1 Expression In vitro and In vivo Cancer Res., July 15, 2007; 67(14): 6981 - 6986. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. Gaspar, L. Li, A. M. Kapoun, S. Medicherla, M. Reddy, G. Li, G. O'Young, D. Quon, M. Henson, D. L. Damm, et al. Inhibition of Transforming Growth Factor beta Signaling Reduces Pancreatic Adenocarcinoma Growth and Invasiveness Mol. Pharmacol., July 1, 2007; 72(1): 152 - 161. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Zhu, W. Wang, D. C. Clarke, and X. Liu Activation of Mps1 Promotes Transforming Growth Factor-beta-independent Smad Signaling J. Biol. Chem., June 22, 2007; 282(25): 18327 - 18338. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hempel, T. How, M. Dong, S. K. Murphy, T. A. Fields, and G. C. Blobe Loss of Betaglycan Expression in Ovarian Cancer: Role in Motility and Invasion Cancer Res., June 1, 2007; 67(11): 5231 - 5238. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takano, F. Kanai, A. Jazag, H. Ijichi, J. Yao, H. Ogawa, N. Enomoto, M. Omata, and A. Nakao Smad4 is Essential for Down-regulation of E-cadherin Induced by TGF-{beta} in Pancreatic Cancer Cell Line PANC-1 J. Biochem., March 1, 2007; 141(3): 345 - 351. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-H. Wang, S.-H. Kim, J. H. Lee, Y.-L. Choi, Y. C. Kim, T. S. Park, Y.-C. Hong, C.-F. Wu, and Y. K. Shin Inactivation of SMAD4 Tumor Suppressor Gene During Gastric Carcinoma Progression Clin. Cancer Res., January 1, 2007; 13(1): 102 - 110. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. Lim and F. M. Hoffmann Smad4 cooperates with lymphoid enhancer-binding factor 1/T cell-specific factor to increase c-myc expression in the absence of TGF-beta signaling PNAS, December 5, 2006; 103(49): 18580 - 18585. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chang, A. H. Brivanlou, and R. M. Harland Function of the Two Xenopus Smad4s in Early Frog Development J. Biol. Chem., October 13, 2006; 281(41): 30794 - 30803. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Wang, H. Han, and D. D. Von Hoff Identification of an Agent Selectively Targeting DPC4 (Deleted in Pancreatic Cancer Locus 4)-Deficient Pancreatic Cancer Cells Cancer Res., October 1, 2006; 66(19): 9722 - 9730. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Zhu, S. Pearson-White, and K. Luo Requirement for the SnoN Oncoprotein in Transforming Growth Factor {beta}-Induced Oncogenic Transformation of Fibroblast Cells Mol. Cell. Biol., December 15, 2005; 25(24): 10731 - 10744. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Payne and C. J. Kemp Tumor suppressor genetics Carcinogenesis, December 1, 2005; 26(12): 2031 - 2045. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. T. Takaesu, E. Herbig, D. Zhitomersky, M. B. O'Connor, and S. J. Newfeld DNA-binding domain mutations in SMAD genes yield dominant-negative proteins or a neomorphic protein that can activate WG target genes in Drosophila Development, November 1, 2005; 132(21): 4883 - 4894. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kang, W. He, S. Tulley, G. P. Gupta, I. Serganova, C.-R. Chen, K. Manova-Todorova, R. Blasberg, W. L. Gerald, and J. Massague Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway PNAS, September 27, 2005; 102(39): 13909 - 13914. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wan, J. Huang, N. C. Jhala, E. M. Tytler, L. Yang, S. M. Vickers, Y. Tang, C. Lu, N. Wang, and X. Cao SCF{beta}-TrCP1 Controls Smad4 Protein Stability in Pancreatic Cancer Cells Am. J. Pathol., May 1, 2005; 166(5): 1379 - 1392. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Alazzouzi, P. Alhopuro, R. Salovaara, H. Sammalkorpi, H. Jarvinen, J.-P. Mecklin, A. Hemminki, S. Schwartz Jr., L. A. Aaltonen, and D. Arango SMAD4 as a Prognostic Marker in Colorectal Cancer Clin. Cancer Res., April 1, 2005; 11(7): 2606 - 2611. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.S. Prime, M. Davies, M. Pring, and I.C. Paterson THE ROLE OF TGF-{beta} IN EPITHELIAL MALIGNANCY AND ITS RELEVANCE TO THE PATHOGENESIS OF ORAL CANCER (PART II) Critical Reviews in Oral Biology & Medicine, November 1, 2004; 15(6): 337 - 347. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Trapasso, S. Yendamuri, K. R. Dumon, R. Iuliano, R. Cesari, B. Feig, R. Seto, L. Infante, H. Ishii, A. Vecchione, et al. Restoration of receptor-type protein tyrosine phosphatase {eta} function inhibits human pancreatic carcinoma cell growth in vitro and in vivo Carcinogenesis, November 1, 2004; 25(11): 2107 - 2114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liang, Y.-Y. Liang, K. Wrighton, D. Ungermannova, X.-P. Wang, F. C. Brunicardi, X. Liu, X.-H. Feng, and X. Lin Ubiquitination and Proteolysis of Cancer-Derived Smad4 Mutants by SCFSkp2 Mol. Cell. Biol., September 1, 2004; 24(17): 7524 - 7537. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. J. Nicolas, K. De Bosscher, B. Schmierer, and C. S. Hill Analysis of Smad nucleocytoplasmic shuttling in living cells J. Cell Sci., August 15, 2004; 117(18): 4113 - 4125. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Subramanian, R. E. Schwarz, L. Higgins, G. McEnroe, S. Chakravarty, S. Dugar, and M. Reiss Targeting Endogenous Transforming Growth Factor {beta} Receptor Signaling in SMAD4-Deficient Human Pancreatic Carcinoma Cells Inhibits Their Invasive Phenotype1 Cancer Res., August 1, 2004; 64(15): 5200 - 5211. [Abstract] [Full Text] [PDF] |
||||
![]() |
J R Howe, M G Sayed, A F Ahmed, J Ringold, J Larsen-Haidle, A Merg, F A Mitros, C A Vaccaro, G M Petersen, F M Giardiello, et al. The prevalence of MADH4 and BMPR1A mutations in juvenile polyposis and absence of BMPR2, BMPR1B, and ACVR1 mutations J. Med. Genet., July 1, 2004; 41(7): 484 - 491. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. H. Kim, H. S. Lee, H.-J. Lee, K. Hur, W. H. Kim, Y.-J. Bang, S.-J. Kim, K. U. Lee, K. J. Choe, and H.-K. Yang Prognostic significance of the expression of Smad4 and Smad7 in human gastric carcinomas Ann. Onc., April 1, 2004; 15(4): 574 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-h. Cheng, J. F. Ponte, and S. Thiagalingam Elucidation of Epigenetic Inactivation of SMAD8 in Cancer Using Targeted Expressed Gene Display Cancer Res., March 1, 2004; 64(5): 1639 - 1646. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Iacobuzio-Donahue, J. Song, G. Parmiagiani, C. J. Yeo, R. H. Hruban, and S. E. Kern Missense Mutations of MADH4: Characterization of the Mutational Hot Spot and Functional Consequences in Human Tumors Clin. Cancer Res., March 1, 2004; 10(5): 1597 - 1604. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Osman, E. G. Niles, and P. T. LoVerde Expression of Functional Schistosoma mansoni Smad4: ROLE IN ERK-MEDIATED TRANSFORMING GROWTH FACTOR {beta} (TGF-{beta}) DOWN-REGULATION J. Biol. Chem., February 20, 2004; 279(8): 6474 - 6486. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Kim and A. B. Lassar Smad-Dependent Recruitment of a Histone Deacetylase/Sin3A Complex Modulates the Bone Morphogenetic Protein-Dependent Transcriptional Repressor Activity of Nkx3.2 Mol. Cell. Biol., December 1, 2003; 23(23): 8704 - 8717. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Tian, S. DaCosta Byfield, W. T. Parks, S. Yoo, A. Felici, B. Tang, E. Piek, L. M. Wakefield, and A. B. Roberts Reduction in Smad2/3 Signaling Enhances Tumorigenesis but Suppresses Metastasis of Breast Cancer Cell Lines Cancer Res., December 1, 2003; 63(23): 8284 - 8292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Blokzijl, C. Dahlqvist, E. Reissmann, A. Falk, A. Moliner, U. Lendahl, and C. F. Ibanez Cross-talk between the Notch and TGF-{beta} signaling pathways mediated by interaction of the Notch intracellular domain with Smad3 J. Cell Biol., November 24, 2003; 163(4): 723 - 728. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. J. Roelen, O. S. Cohen, M. K. Raychowdhury, D. N. Chadee, Y. Zhang, J. M. Kyriakis, A. A. Alessandrini, and H. Y. Lin Phosphorylation of threonine 276 in Smad4 is involved in transforming growth factor-{beta}-induced nuclear accumulation Am J Physiol Cell Physiol, October 1, 2003; 285(4): C823 - C830. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, M. Lundin, A. Ristimaki, P. Heikkila, J. Lundin, J. Isola, H. Joensuu, and M. Laiho Ski-related novel protein N (SnoN), a Negative Controller of Transforming Growth Factor-{beta} Signaling, Is a Prognostic Marker in Estrogen Receptor-positive Breast Carcinomas , Cancer Res., August 15, 2003; 63(16): 5005 - 5010. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Dumont, F. Lallemand, C. Prunier, N. Ferrand, A. Guillouzo, B. Clement, A. Atfi, and N. Theret Evidence for a Role of Smad3 and Smad2 in Stabilization of the Tumor-derived Mutant Smad2.Q407R J. Biol. Chem., June 27, 2003; 278(27): 24881 - 24887. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. L. Baldwin, H. Tran, and B. Y. Karlan Loss of c-myc Repression Coincides with Ovarian Cancer Resistance to Transforming Growth Factor {beta} Growth Arrest Independent of Transforming Growth Factor {beta}/Smad Signaling Cancer Res., March 15, 2003; 63(6): 1413 - 1419. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Hempen, L. Zhang, R. K. Bansal, C. A. Iacobuzio-Donahue, K. M. Murphy, A. Maitra, B. Vogelstein, R. H. Whitehead, S. D. Markowitz, J. K. V. Willson, et al. Evidence of Selection for Clones Having Genetic Inactivation of the Activin A Type II Receptor (ACVR2) Gene in Gastrointestinal Cancers Cancer Res., March 1, 2003; 63(5): 994 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. House, M. Guo, C. Iacobuzio-Donahue, and J. G. Herman Molecular progression of promoter methylation in intraductal papillary mucinous neoplasms (IPMN) of the pancreas Carcinogenesis, February 1, 2003; 24(2): 193 - 198. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Dumont, A. V. Bakin, and C. L. Arteaga Autocrine Transforming Growth Factor-beta Signaling Mediates Smad-independent Motility in Human Cancer Cells J. Biol. Chem., January 24, 2003; 278(5): 3275 - 3285. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Cheng and J. P. Grande Transforming Growth Factor-{beta} Signal Transduction and Progressive Renal Disease Experimental Biology and Medicine, December 1, 2002; 227(11): 943 - 956. [Abstract] [Full Text] |
||||
![]() |
H.-Y. Kang, K.-E. Huang, S. Y. Chang, W.-L. Ma, W.-J. Lin, and C. Chang Differential Modulation of Androgen Receptor-mediated Transactivation by Smad3 and Tumor Suppressor Smad4 J. Biol. Chem., November 8, 2002; 277(46): 43749 - 43756. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ramachandra, I. Atencio, A. Rahman, M. Vaillancourt, A. Zou, J. Avanzini, K. Wills, R. Bookstein, and P. Shabram Restoration of Transforming Growth Factor {beta} Signaling by Functional Expression of Smad4 Induces Anoikis Cancer Res., November 1, 2002; 62(21): 6045 - 6051. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Peng, J. B. Fleming, T. Breslin, A. M. Grau, S. Fojioka, J. L. Abbruzzese, D. B. Evans, D. Ayers, K. Wathen, T. Wu, et al. Suppression of Tumorigenesis and Induction of p15ink4b by Smad4/DPC4 in Human Pancreatic Cancer Cells Clin. Cancer Res., November 1, 2002; 8(11): 3628 - 3638. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Edmunds, D. P. Kelsell, J. L. Hungerford, and I. A. Cree Mutational Analysis of Selected Genes in the TGF{beta}, Wnt, pRb, and p53 Pathways in Primary Uveal Melanoma Invest. Ophthalmol. Vis. Sci., September 1, 2002; 43(9): 2845 - 2851. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Samatar, L. Wang, A. Mirza, S. Koseoglu, S. Liu, and C. C. Kumar Transforming Growth Factor-beta 2 Is a Transcriptional Target for Akt/Protein Kinase B via Forkhead Transcription Factor J. Biol. Chem., July 26, 2002; 277(31): 28118 - 28126. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Murphy, K. A. Brune, C. Griffin, J. E. Sollenberger, G. M. Petersen, R. Bansal, R. H. Hruban, and S. E. Kern Evaluation of Candidate Genes MAP2K4, MADH4, ACVR1B, and BRCA2 in Familial Pancreatic Cancer: Deleterious BRCA2 Mutations in 17% Cancer Res., July 1, 2002; 62(13): 3789 - 3793. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Natsugoe, C. Xiangming, M. Matsumoto, H. Okumura, S. Nakashima, H. Sakita, S. Ishigami, M. Baba, S. Takao, and T. Aikou Smad4 and Transforming Growth Factor {beta}1 Expression in Patients with Squamous Cell Carcinoma of the Esophagus Clin. Cancer Res., June 1, 2002; 8(6): 1838 - 1842. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yan, G.-Y. Kim, X. Deng, and E. Friedman Transforming Growth Factor beta 1 Induces Proliferation in Colon Carcinoma Cells by Ras-dependent, smad-independent Down-regulation of p21cip1 J. Biol. Chem., March 15, 2002; 277(12): 9870 - 9879. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Xie, J. C. Mertens, D. J. Reiss, D. L. Rimm, R. L. Camp, B. G. Haffty, and M. Reiss Alterations of Smad Signaling in Human Breast Carcinoma Are Associated with Poor Outcome: A Tissue Microarray Study Cancer Res., January 1, 2002; 62(2): 497 - 505. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Risbridger, J. F. Schmitt, and D. M. Robertson Activins and Inhibins in Endocrine and Other Tumors Endocr. Rev., December 1, 2001; 22(6): 836 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Maurice, C. E. Pierreux, M. Howell, R. E. Wilentz, M. J. Owen, and C. S. Hill Loss of Smad4 Function in Pancreatic Tumors. C-TERMINAL TRUNCATION LEADS TO DECREASED STABILITY J. Biol. Chem., November 9, 2001; 276(46): 43175 - 43181. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Osada, Y. Tatematsu, A. Masuda, T. Saito, M. Sugiyama, K. Yanagisawa, and T. Takahashi Heterogeneous Transforming Growth Factor (TGF)-{beta} Unresponsiveness and Loss of TGF-{beta} Receptor Type II Expression Caused by Histone Deacetylation in Lung Cancer Cell Lines Cancer Res., November 1, 2001; 61(22): 8331 - 8339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Abraham, T.-T. Wu, D. S. Klimstra, L. S. Finn, J.-H. Lee, C. J. Yeo, J. L. Cameron, and R. H. Hruban Distinctive Molecular Genetic Alterations in Sporadic and Familial Adenomatous Polyposis-Associated Pancreatoblastomas : Frequent Alterations in the APC/{beta}-Catenin Pathway and Chromosome 11p Am. J. Pathol., November 1, 2001; 159(5): 1619 - 1627. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-L. Wu, S. D. Kirley, H. Xiao, Y. Chuang, D. C. Chung, and L. R. Zukerberg Cables Enhances Cdk2 Tyrosine 15 Phosphorylation by Wee1, Inhibits Cell Growth, and Is Lost in Many Human Colon and Squamous Cancers Cancer Res., October 1, 2001; 61(19): 7325 - 7332. [Abstract] [Full Text] [PDF] |
||||
![]() |
A J Alvi, J S Rader, M Broggini, F Latif, and E R Maher Microsatellite instability and mutational analysis of transforming growth factor {beta} receptor type II gene (TGFBR2) in sporadic ovarian cancer Mol. Pathol., August 1, 2001; 54(4): 240 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Venkatasubbarao, S. Ammanamanchi, M. G. Brattain, D. Mimari, and J. W. Freeman Reversion of Transcriptional Repression of Sp1 by 5 aza-2' Deoxycytidine Restores TGF-{beta} Type II Receptor Expression in the Pancreatic Cancer Cell Line MIA PaCa-2 Cancer Res., August 1, 2001; 61(16): 6239 - 6247. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Lassus, R. Salovaara, L. A. Aaltonen, and R. Butzow Allelic Analysis of Serous Ovarian Carcinoma Reveals Two Putative Tumor Suppressor Loci at 18q22-q23 Distal to SMAD4, SMAD2, and DCC Am. J. Pathol., July 1, 2001; 159(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhang, K. Graziano, T. Pham, C. D. Logsdon, and D. M. Simeone Adenovirus-mediated gene transfer of dominant-negative Smad4 blocks TGF-{beta} signaling in pancreatic acinar cells Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1247 - G1253. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Wilentz, P. Argani, and R. H. Hruban Loss of Heterozygosity or Intragenic Mutation, Which Comes First? Am. J. Pathol., May 1, 2001; 158(5): 1561 - 1563. [Full Text] [PDF] |
||||
![]() |
G. H. Su, R. Bansal, K. M. Murphy, E. Montgomery, C. J. Yeo, R. H. Hruban, and S. E. Kern ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma PNAS, March 13, 2001; 98(6): 3254 - 3257. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. K. Lee, S. H. Park, Y. Yi, S.-G. Choi, C. Lee, W. T. Parks, H. Cho, M. P. de Caestecker, Y. Shaul, A. B. Roberts, et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-{beta} family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis Genes & Dev., February 15, 2001; 15(4): 455 - 466. [Abstract] [Full Text] |
||||
![]() |
S. W. Tobin, M. K. Brown, K. Douville, D. C. Payne, A. Eastman, and B. A. Arrick Inhibition of Transforming Growth Factor {beta} Signaling in MCF-7 Cells Results in Resistance to Tumor Necrosis Factor {{alpha}}: A Role for Bcl-2 Cell Growth Differ., February 1, 2001; 12(2): 109 - 117. [Abstract] [Full Text] |
||||
![]() |
C. Xiangming, S. Natsugoe, S. Takao, S. Hokita, S. Ishigami, G. Tanabe, M. Baba, K. Kuroshima, and T. Aikou Preserved Smad4 Expression in the Transforming Growth Factor {beta} Signaling Pathway Is a Favorable Prognostic Factor in Patients with Advanced Gastric Cancer Clin. Cancer Res., February 1, 2001; 7(2): 277 - 282. [Abstract] [Full Text] |
||||
![]() |
E. Montgomery, M. Goggins, S. Zhou, P. Argani, R. E. Wilentz, M. Kaushal, S. Booker, K. Romans, P. Bhargava, R. H. Hruban, et al. Nuclear Localization of Dpc4 (Madh4, Smad4) in Colorectal Carcinomas and Relation to Mismatch Repair/Transforming Growth Factor-{beta} Receptor Defects Am. J. Pathol., February 1, 2001; 158(2): 537 - 542. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Chen, Y. Kang, and J. Massague Inaugural Article: Defective repression of c-myc in breast cancer cells: A loss at the core of the transforming growth factor beta growth arrest program PNAS, January 30, 2001; 98(3): 992 - 999. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Park, M. C. Birchenall-Roberts, Y. Yi, B. I. Lee, D. K. Lee, D. C. Bertolette, T. Fu, F. Ruscetti, and S.-J. Kim Mechanism of Induction of Transforming Growth Factor-{beta} Type II Receptor Gene Expression by v-Src in Murine Myeloid Cells Cell Growth Differ., January 1, 2001; 12(1): 9 - 18. [Abstract] [Full Text] |
||||
![]() |
S. P. Fink, S. E. Swinler, J. D. Lutterbaugh, J. Massagué, S. Thiagalingam, K. W. Kinzler, B. Vogelstein, J. K. V. Willson, and S. Markowitz Transforming Growth Factor-{beta}-induced Growth Inhibition in a Smad4 Mutant Colon Adenoma Cell Line Cancer Res., January 1, 2001; 61(1): 256 - 260. [Abstract] [Full Text] |
||||
![]() |
C. E. Pierreux, F. J. Nicolás, and C. S. Hill Transforming Growth Factor beta -Independent Shuttling of Smad4 between the Cytoplasm and Nucleus Mol. Cell. Biol., December 1, 2000; 20(23): 9041 - 9054. [Abstract] [Full Text] |
||||
![]() |
J. N. Rao, L. Li, B. L. Bass, and J.-Y. Wang Expression of the TGF-beta receptor gene and sensitivity to growth inhibition following polyamine depletion Am J Physiol Cell Physiol, October 1, 2000; 279(4): C1034 - C1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. de Caestecker, E. Piek, and A. B. Roberts Role of Transforming Growth Factor-{beta} Signaling in Cancer J Natl Cancer Inst, September 6, 2000; 92(17): 1388 - 1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Iacobuzio-Donahue, D. S. Klimstra, N. V. Adsay, R. E. Wilentz, P. Argani, T. A. Sohn, C. J. Yeo, J. L. Cameron, S. E. Kern, and R. H. Hruban Dpc-4 Protein Is Expressed in Virtually All Human Intraductal Papillary Mucinous Neoplasms of the Pancreas : Comparison with Conventional Ductal Adenocarcinomas Am. J. Pathol., September 1, 2000; 157(3): 755 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Schwarte-Waldhoff, O. V. Volpert, N. P. Bouck, B. Sipos, S. A. Hahn, S. Klein-Scory, J. Luttges, G. Kloppel, U. Graeven, C. Eilert-Micus, et al. Smad4/DPC4-mediated tumor suppression through suppression of angiogenesis PNAS, August 15, 2000; 97(17): 9624 - 9629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Jones and S. E. Kern Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4 Nucleic Acids Res., June 15, 2000; 28(12): 2363 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamano, H. Fujii, T. Takagaki, N. Kadowaki, H. Watanabe, and T. Shirai Genetic Progression and Divergence in Pancreatic Carcinoma Am. J. Pathol., June 1, 2000; 156(6): 2123 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Woodford-Richens, S Bevan, M Churchman, B Dowling, D Jones, C G Norbury, S V Hodgson, D Desai, K Neale, R K S Phillips, et al. Analysis of genetic and phenotypic heterogeneity in juvenile polyposis Gut, May 1, 2000; 46(5): 656 - 660. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu and L. Attisano Mutations in the tumor suppressors Smad2 and Smad4 inactivate transforming growth factor beta signaling by targeting Smads to the ubiquitin-proteasome pathway PNAS, April 25, 2000; 97(9): 4820 - 4825. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Wilentz, C. A. Iacobuzio-Donahue, P. Argani, D. M. McCarthy, J. L. Parsons, C. J. Yeo, S. E. Kern, and R. H. Hruban Loss of Expression of Dpc4 in Pancreatic Intraepithelial Neoplasia: Evidence That DPC4 Inactivation Occurs Late in Neoplastic Progression Cancer Res., April 1, 2000; 60(7): 2002 - 2006. [Abstract] [Full Text] |
||||
![]() |
K. Matsuzaki, M. Date, F. Furukawa, Y. Tahashi, M. Matsushita, K. Sakitani, N. Yamashiki, T. Seki, H. Saito, M. Nishizawa, et al. Autocrine Stimulatory Mechanism by Transforming Growth Factor {beta} in Human Hepatocellular Carcinoma Cancer Res., March 1, 2000; 60(5): 1394 - 1402. [Abstract] [Full Text] |
||||
![]() |
M. Bouras, E. Tabone, J. Bertholon, P. Sommer, R. Bouvier, J.-P. Droz, and M. Benahmed A Novel SMAD4 Gene Mutation in Seminoma Germ Cell Tumors Cancer Res., February 1, 2000; 60(4): 922 - 928. [Abstract] [Full Text] |
||||
![]() |
M. Tan, Y. Wang, K. Guan, and Y. Sun PTGF-beta , a type beta transforming growth factor (TGF-beta ) superfamily member, is a p53 target gene that inhibits tumor cell growth via TGF-beta signaling pathway PNAS, January 4, 2000; 97(1): 109 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. MacDougall and L. Matrisian Targets of extinction: identification of genes whose expression is repressed as a consequence of somatic fusion between cells representing basal and luminal mammary epithelial phenotypes J. Cell Sci., January 2, 2000; 113(3): 409 - 423. [Abstract] [PDF] |
||||
![]() |
S. Larisch-Bloch, D. Danielpour, N. S. Roche, R. Lotan, A. Y. Hsing, H. Kerner, T. Hajouj, R. J. Lechleider, and A. B. Roberts Selective Loss of the Transforming Growth Factor-{beta} Apoptotic Signaling Pathway in Mutant NRP-154 Rat Prostatic Epithelial Cells Cell Growth Differ., January 1, 2000; 11(1): 1 - 10. [Abstract] [Full Text] |
||||
![]() |
R. E. Wilentz, G. H. Su, J. L. Dai, A. B. Sparks, P. Argani, T. A. Sohn, C. J. Yeo, S. E. Kern, and R. H. Hruban Immunohistochemical Labeling for Dpc4 Mirrors Genetic Status in Pancreatic Adenocarcinomas : A New Marker of DPC4 Inactivation Am. J. Pathol., January 1, 2000; 156(1): 37 - 43. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Engel, M. A. McDonnell, B. K. Law, and H. L. Moses Interdependent SMAD and JNK Signaling in Transforming Growth Factor-beta -mediated Transcription J. Biol. Chem., December 24, 1999; 274(52): 37413 - 37420. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. PIEK, C.-H. HELDIN, and P. TEN DIJKE Specificity, diversity, and regulation in TGF-{beta} superfamily signaling FASEB J, December 1, 1999; 13(15): 2105 - 2124. [Abstract] [Full Text] |
||||
![]() |
M. J. Calonge and J. Massague Smad4/DPC4 Silencing and Hyperactive Ras Jointly Disrupt Transforming Growth Factor-beta Antiproliferative Responses in Colon Cancer Cells J. Biol. Chem., November 19, 1999; 274(47): 33637 - 33643. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pasche, P. Kolachana, K. Nafa, J. Satagopan, Y.-G. Chen, R. S. Lo, D. Brener, D. Yang, L. Kirstein, C. Oddoux, et al. T{{beta}}R-I(6A) Is a Candidate Tumor Susceptibility Allele Cancer Res., November 1, 1999; 59(22): 5678 - 5682. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Bruening, A. H. Prowse, D. C. Schultz, M. Holgado-Madruga, A. Wong, and A. K. Godwin Expression of OVCA1, a Candidate Tumor Suppressor, Is Reduced in Tumors and Inhibits Growth of Ovarian Cancer Cells Cancer Res., October 1, 1999; 59(19): 4973 - 4983. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Knuutila, Y. Aalto, K. Autio, A.-M. Bjorkqvist, W.'e. El-Rifai, S. Hemmer, T. Huhta, E. Kettunen, S. Kiuru-Kuhlefelt, M. L. Larramendy, et al. DNA Copy Number Losses in Human Neoplasms Am. J. Pathol., September 1, 1999; 155(3): 683 - 694. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Anbazhagan, D. M. Bornman, J. C. Johnston, W. H. Westra, and E. Gabrielson The S387Y Mutation of the Transforming Growth Factor-{beta} Receptor Type I Gene Is Uncommon in Metastases of Breast Cancer and Other Common Types of Adenocarcinoma Cancer Res., July 1, 1999; 59(14): 3363 - 3364. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Stroschein, W. Wang, and K. Luo Cooperative Binding of Smad Proteins to Two Adjacent DNA Elements in the Plasminogen Activator Inhibitor-1 Promoter Mediates Transforming Growth Factor beta -induced Smad-dependent Transcriptional Activation J. Biol. Chem., April 2, 1999; 274(14): 9431 - 9441. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Datto, J. P. Frederick, L. Pan, A. J. Borton, Y. Zhuang, and X.-F. Wang Targeted Disruption of Smad3 Reveals an Essential Role in Transforming Growth Factor beta -Mediated Signal Transduction Mol. Cell. Biol., April 1, 1999; 19(4): 2495 - 2504. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Dai, R. K. Bansal, and S. E. Kern G1 cell cycle arrest and apoptosis induction by nuclear Smad4/Dpc4: Phenotypes reversed by a tumorigenic mutation PNAS, February 16, 1999; 96(4): 1427 - 1432. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Rodeck, T. Nishiyama, and A. Mauviel Independent Regulation of Growth and SMAD-mediated Transcription by Transforming Growth Factor {beta} in Human Melanoma Cells Cancer Res., February 1, 1999; 59(3): 547 - 550. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Grady, L. L. Myeroff, S. E. Swinler, A. Rajput, S. Thiagalingam, J. D. Lutterbaugh, A. Neumann, M. G. Brattain, J. Chang, S.-J. Kim, et al. Mutational Inactivation of Transforming Growth Factor {beta} Receptor Type II in Microsatellite Stable Colon Cancers Cancer Res., January 1, 1999; 59(2): 320 - 324. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Suh, Y. Wang, T. Honda, G. W. Gribble, E. Dmitrovsky, W. F. Hickey, R. A. Maue, A. E. Place, D. M. Porter, M. J. Spinella, et al. A Novel Synthetic Oleanane Triterpenoid, 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid, with Potent Differentiating, Antiproliferative, and Anti-Inflammatory Activity Cancer Res., January 1, 1999; 59(2): 336 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Sun, P. Dong, K. Dai, G. J. Hannon, and D. Beach p53-Independent Role of MDM2 in TGF-1 Resistance Science, December 18, 1998; 282(5397): 2270 - 2272. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |